ProZ.com global directory of translation services
 The translation workplace
KudoZ home » German to English » Medical: Pharmaceuticals

Anzeigeverpflichtungen

English translation: (regulatory) reporting obligations


GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW)
German term or phrase:Anzeigeverpflichtungen
English translation:(regulatory) reporting obligations
Entered by: Susanne Schiewe (medical & IT translations)
Options:
- Contribute to this entry

16:27 Oct 28, 2009Login or register (free) for more options.
German to English translations [PRO]
Science - Medical: Pharmaceuticals / Pharmacovigilance
German term or phrase: Anzeigeverpflichtungen
from an SOP re processing complaints:
Pharmacovigilance Manager ist verantwortlich für: Initialbewertung aller Reklamationen, Risikoabschätzung und Einhaltung möglicher gesetzlicher Anzeigeverpflichtungen.

I think the „Anzeigeverpflichtungen“ arise under the AMG – I’ve seen this transalted as "reporting duties“ but is there a more common term for this?
KenOldfield
(regulatory) reporting obligations
Explanation:
.

--------------------------------------------------
Note added at 14 Min. (2009-10-28 16:42:17 GMT)
--------------------------------------------------

Uponstudy closure, the investigator will be required to certify that the study wasconducted and the Pfizer grant funds and/or drug were used solely toconduct or report the study and that all safety reporting obligations weremet.
http://209.85.129.132/search?q=cache:MWGF3psX4WsJ:media.pfiz...

--------------------------------------------------
Note added at 17 Min. (2009-10-28 16:44:53 GMT)
--------------------------------------------------

Additional Reporting Obligations for Investigators-Sponsors

When an Investigator files an IND, the Investigator is considered the Sponsor and as such carries all of the FDA regulatory responsibilities and reporting obligations of both the Investigator and Sponsor as outlined below described in the FDA regulations 21 CFR 312 (drugs) and 21 CFR 601 (biologics). Please refer to the regulations for complete information.

• FDA reporting obligations of investigators under an IND include:
• Drug disposition
• Case histories
• Progress reports
• Safety reports
• Final report
• Financial disclosure report

Specific record keeping and record retention
• FDA reporting obligations of sponsors under an IND include:
• Protocol amendments
• Information amendments
• IND Safety Reports
• Annual Reports
• Withdrawal of an IND

Specific record keeping and retention
http://www.research.ucsf.edu/chr/guide/chrIND.asp#10
Selected response from:

Susanne Schiewe (medical & IT translations)
Germany
Local time: 14:31
Grading comment
Many thanks
3 KudoZ points were awarded for this answer



Summary of answers provided
3 +2(regulatory) reporting obligations
Susanne Schiewe (medical & IT translations)
4statutory reporting obligationsivara


  

Answers


16 mins   confidence: Answerer confidence 4/5Answerer confidence 4/5
statutory reporting obligation


Explanation:
statutory sounds better to me and shows more emphasis on the legal/ statutorial aspect

sivara
United Kingdom
Local time: 13:31
Native speaker of: Native in GermanGerman
Login to enter a peer comment (or grade)

13 mins   confidence: Answerer confidence 3/5Answerer confidence 3/5 peer agreement (net): +2
(regulatory) reporting obligations


Explanation:
.

--------------------------------------------------
Note added at 14 Min. (2009-10-28 16:42:17 GMT)
--------------------------------------------------

Uponstudy closure, the investigator will be required to certify that the study wasconducted and the Pfizer grant funds and/or drug were used solely toconduct or report the study and that all safety reporting obligations weremet.
http://209.85.129.132/search?q=cache:MWGF3psX4WsJ:media.pfiz...

--------------------------------------------------
Note added at 17 Min. (2009-10-28 16:44:53 GMT)
--------------------------------------------------

Additional Reporting Obligations for Investigators-Sponsors

When an Investigator files an IND, the Investigator is considered the Sponsor and as such carries all of the FDA regulatory responsibilities and reporting obligations of both the Investigator and Sponsor as outlined below described in the FDA regulations 21 CFR 312 (drugs) and 21 CFR 601 (biologics). Please refer to the regulations for complete information.

• FDA reporting obligations of investigators under an IND include:
• Drug disposition
• Case histories
• Progress reports
• Safety reports
• Final report
• Financial disclosure report

Specific record keeping and record retention
• FDA reporting obligations of sponsors under an IND include:
• Protocol amendments
• Information amendments
• IND Safety Reports
• Annual Reports
• Withdrawal of an IND

Specific record keeping and retention
http://www.research.ucsf.edu/chr/guide/chrIND.asp#10

Susanne Schiewe (medical & IT translations)
Germany
Local time: 14:31
Specializes in field
Native speaker of: Native in GermanGerman
PRO pts in category: 22
Grading comment
Many thanks

Peer comments on this answer (and responses from the answerer)
agree  Goldcoaster
1 hr
  -> danke, Goldcoaster

agree  MMUlr: correct, however, your URLs are from the "clinical study setting"; this context is usual pharmacovigilance: -> http://www.emea.europa.eu/pdfs/human/phvwp/161801en.pdf (find: reporting)
18 hrs
  -> yes, in fact - thank you!
Login to enter a peer comment (or grade)




Return to KudoZ list


KudoZ™ translation help
The KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases.


See also: